ArticleCancer immunology, immunotherapy : CII2020

Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditions.

Zhenyuan Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.